Got migraines? FDA approved Pfizer’s nasal spray treatment
The US Food and Drug Administration (FDA) approved Pfizer’s rapid nasal spray to treat migraines. Pfizer expects the drug, marketed under the name Zavzpret, to be available in pharmacies by July 2023. “The FDA approval of Zavzpret marks a significant breakthrough for people with migraine who need freedom from pain and prefer alternative options to […]
Continue Reading